← back to search

Saskia du Pré

University of Manchester · GB
Area of research
Infectious Diseases · Pharmacology
Research interest
Research interests include Dihydroorotate dehydrogenase, Antifungal, Pyrimidine metabolism, Antifungal drug, Drug resistance, and Aspergillus niger.
h-index
citations
311
works
2
NIH funding
primary concept
email

Recent publications

The pathway intermediate 2‐keto‐3‐deoxy‐L‐galactonate mediates the induction of genes involved in D‐galacturonic acid utilization in <i>Aspergillus niger</i>
FEBS Letters 2017cited by 31position: middledoi
F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase
Proceedings of the National Academy of Sciences 2016cited by 280position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2017–2017)Nathan P. Wiederhold · The University of Texas Health Science Center at San Antonio1 papers (2016–2016)Jason D. Oliver · University of Manchester1 papers (2016–2016)Ronald P. de Vries · Utrecht University1 papers (2017–2017) · 1 papers (2016–2016)Joanne Livermore · University of Liverpool1 papers (2016–2016)Derek Law · University of Manchester1 papers (2016–2016)Jaap Visser · Utrecht University1 papers (2017–2017) · 1 papers (2017–2017)Mao Peng · Utrecht University1 papers (2017–2017) · 1 papers (2016–2016)A. J. Kennedy · University of Manchester1 papers (2016–2016) · 1 papers (2017–2017)Laura McEntee · University of Liverpool1 papers (2016–2016)María Victoria Aguilar Pontes · Utrecht University1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2017–2017)Graham E. M. Sibley · University of Manchester1 papers (2016–2016)William Hope · University of Liverpool1 papers (2016–2016) · 1 papers (2017–2017)